BIOMAT Database Logo BIOMAT Database Logo

Primary drug resistance of Mycobacterium tuberculosis to antituberculosis drugs. 1988

M I Safi, and S Zai

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

M I Safi, and S Zai
[Surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs].
September 2008, Biomedica : revista del Instituto Nacional de Salud,
M I Safi, and S Zai
Mycobacterium tuberculosis resistance to antituberculosis drugs in Mozambique.
January 2014, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia,
M I Safi, and S Zai
Optimizing the use of current antituberculosis drugs to overcome drug resistance in Mycobacterium tuberculosis.
February 2024, Infectious diseases now,
M I Safi, and S Zai
[Resistance of Mycobacterium tuberculosis strains isolated from patients to antituberculosis drugs].
January 2001, Mikrobiolohichnyi zhurnal (Kiev, Ukraine : 1993),
M I Safi, and S Zai
Molecular detection methods of resistance to antituberculosis drugs in Mycobacterium tuberculosis.
September 2017, Medecine et maladies infectieuses,
M I Safi, and S Zai
Pattern of drug resistance of Mycobacterium tuberculosis clinical isolates to first-line antituberculosis drugs in pulmonary cases.
January 2015, Lung India : official organ of Indian Chest Society,
M I Safi, and S Zai
[Primary drug resistance of Mycobacterium tuberculosis to antitubercular drugs and its clinical significance].
January 1975, Problemy tuberkuleza,
M I Safi, and S Zai
[Primary drug resistance of Mycobacterium tuberculosis].
January 1972, Problemy tuberkuleza,
M I Safi, and S Zai
Resistance to Antituberculosis Drugs in Pulmonary Tuberculosis.
October 2006, Medical journal, Armed Forces India,
M I Safi, and S Zai
Resistance of Mycobacterium tuberculosis to antituberculosis drugs in the Central Region of Thailand, 1996.
August 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Copied contents to your clipboard!